Araz Marachelian Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• A Phase I Study of Lenalidomide in Combination with ch14.18 and isotretinoin in Patients with Refractory/Recurrent Neuroblastoma (RR-NB): New Approaches to Neuroblastoma Therapy (NANT) Consortium Trial — Parallel 14 Clinical Awards Session